Allergy Therapeutics PLC Stock
Price
Target price
€0.082
€0.082
-0.610%
-0.0005
-0.610%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Allergy Therapeutics PLC Stock
The price for the Allergy Therapeutics PLC stock decreased slightly today. Compared to yesterday there is a change of -€0.001 (-0.610%).
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | -0.610% | -1.796% | -5.202% | 49.091% | 19.708% | -57.949% | -45.333% |
| Beximco Pharmaceuticals Ltd. GDR | -14.290% | -5.858% | -10.000% | 13.065% | 8.173% | -39.189% | -26.230% |
| SELLAS Life Sciences Group Inc | -0.730% | -9.892% | 15.268% | 56.636% | 78.108% | -35.315% | -23.991% |
| Eledon Pharmaceuticals Inc. | -1.340% | 28.947% | 38.679% | 7.299% | -27.941% | 17.600% | -79.368% |
News
AT&T Just Delivered for Investors. It's Not Too Late to Buy the Stock.
Telecom giant AT&T (NYSE: T) has a simple growth strategy: Win high-value customers who use its wireless and fiber services together. The company picked up plenty of those so-called "converged"
2 Surefire Dividend Stocks to Buy for the Long Haul
In 2022 and 2023, rising interest rates drove many income investors to sell their dividend stocks and buy risk-free CDs and T-bills for higher yields. But as interest rates decline again, many of
St. Louis Financial Sells $3.3 Million in AT&T Stock With Next Earnings on Deck
St. Louis Financial Planners Asset Management, LLC disclosed in a Thursday filing with the SEC that it sold shares of AT&T worth an estimated $3.3 million in the third quarter.
According to a